Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.01
0.03 (2.95%)
At close: Aug 15, 2025, 3:59 PM
1.01
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Lucid Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.17B 4.17M 4.35M 4.19M 3.8M 2.98M 2.43M 1.5M 793K 634K 377K 565K 689K 689K 500K 200K n/a n/a
Cost of Revenue
1.57B 6.99M 7.1M 6.41M 6.36M 6.3M 5.98M 6.14M 6.13M 5.29M 4.32M 3.14M 1.66M 954K 587.78K 147.06K 2.79K 2.79K
Gross Profit
-402.18M -2.82M -2.75M -2.22M -2.56M -3.31M -3.55M -4.64M -5.34M -4.65M -3.94M -2.58M -969.27K -265.49K -88.28K 52.72K -3K -2.79K
Operating Income
-11.42B -47.75M -46.05M -45.13M -44.56M -44.96M -48.48M -51.96M -55.21M -58.25M -56.2M -52.52M -44.65M -36.04M -27.42M -18.91M -14.42M -9.72M
Interest Income
110.21M 320K 322K 350K 385K 414K 424K 330K 242K 110K 33K 33K 5K 1K n/a n/a n/a n/a
Pretax Income
-4.49B -61.83M -45.53M -44.82M -46.66M -47.03M -52.67M -56.76M -56.91M -60.15M -56.17M -52.55M -45.16M -36.7M -28.08M -19.5M -14.57M -9.72M
Net Income
-7.94B -61.83M -45.53M -44.82M -46.66M -47.03M -2.02B -2.02B -2.02B -2.02B -56M -52.55M -45.16M -36.7M -28.08M -19.5M -14.57M -9.72M
Selling & General & Admin
9.65B 38.59M 36.62M 35.37M 34.11M 32.9M 35.66M 37.52M 38.95M 41.64M 39.82M 36.97M 31.75M 25.35M 18.04M 11.32M 7.75M 4.05M
Research & Development
1.26B 5.92M 5.99M 6.46M 6.41M 6.86M 7.25M 7.78M 8.87M 10.48M 11.47M 12.51M 11.99M 10.43M 9.3M 7.64M 6.67M 5.66M
Other Expenses
105.32M 421K 688K 1.09M 1.49M 1.89M 2.02M 2.02M 2.02M 1.51M 1.01M 505K n/a n/a n/a n/a n/a n/a
Operating Expenses
11.02B 44.93M 43.3M 42.91M 42M 41.64M 44.93M 47.32M 49.84M 53.57M 52.23M 49.91M 43.68M 35.77M 27.34M 18.97M 14.42M 9.72M
Interest Expense
-5.98M 23K 26K 30K 178K 395K 416K 405K 256K 33K n/a 65.19K 512K 659K 659K 593.81K 147K n/a
Selling & Marketing Expenses
4.02B 16.34M 16.46M 16.87M 16.65M 16.47M 16.4M 17.01M 17.1M 16.94M 16.13M 16.38M 13.37M 10.52M 7.89M 3.26M 2.68M 1.66M
Cost & Expenses
12.56B 26.19M 24.67M 23.59M 48.37M 47.94M 50.91M 53.46M 55.97M 58.85M 56.55M 53.05M 45.33M 36.73M 27.92M 19.11M 14.42M 9.72M
Income Tax Expense
3.45B n/a n/a n/a n/a n/a 1.96B 1.96B 1.96B 1.96B -169K 69.19K 69.19K 65.19K 65.41K 219.00 219.00 219.00
Shares Outstanding (Basic)
98.99M 68.8M 57.7M 50.37M 48.21M 45.01M 41.76M 41.86M 41.83M 40.97M 37.34M 36.41M 35.76M 35.12M 36.99M 36.81M 36.99M 36.99M
Shares Outstanding (Diluted)
98.99M 68.8M 57.7M 50.37M 48.21M 45.01M 41.76M 41.86M 41.83M 40.97M 37.34M 36.41M 35.76M 35.12M 36.99M 36.99M 36.99M 36.99M
EPS (Basic)
-1.05 -1.2 -1.08 -1.14 -1.23 -1.27 -49.18 -49.32 -49.37 -49.51 -1.55 -1.46 -1.26 -1.02 -0.77 -0.53 -0.4 -0.26
EPS (Diluted)
-1.05 -1.2 -1.08 -1.14 -1.23 -1.27 -49.18 -49.32 -49.37 -49.51 -1.55 -1.46 -1.26 -1.02 -0.77 -0.53 -0.4 -0.26
EBITDA
-11.43B -60.91M -44.34M -43.21M -44.49M -44.25M -49.75M -53.87M -54.2M -57.59M -54.23M -51.16M -43.92M -36.01M -27.42M -18.91M -14.42M -8.4M
EBIT
-50.8M -61.8M -45.5M -44.79M -46.48M -46.64M -52.25M -56.36M -56.65M -60.12M -56.17M -52.48M -44.64M -36.04M -27.42M -18.91M -14.42M -9.72M
Depreciation & Amortization
658K 887K 1.17M 1.57M 1.98M 2.39M 2.5M 2.48M 2.45M 2.52M 1.94M 1.32M 729K 25.21K 4K 2.73M 4.76M 6.07M